Abstract: The present invention provides a method of selecting and preventing an IgE-related disease in a subject in need thereof, the method including: (a) selecting a subject at risk of developing an IgE-related disease; and (b) topically administering to the subject a therapeutically effective amount of a composition capable of restoring skin barrier and orally administering to the subject a therapeutically effective amount of a composition including an allergen.
Type:
Grant
Filed:
August 11, 2020
Date of Patent:
August 25, 2026
Assignee:
MY-OR DIAGNOSTICS LTD.
Inventors:
Ron Kohn, Michael Brandwein, Ariel Katz